UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 4, 2023
Accession Number:
0001628280-23-014558
Submission Type:
POS AM
CIK:
0001821586
Company Name:
MoonLake Immunotherapeutics
File Number:
333-262643